High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality.
about
Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cellsAge-related alterations in retinal neurovascular and inflammatory transcriptsRole of breast regression protein-39/YKL-40 in asthma and allergic responsesMaintenance of naïve CD8 T cells in nonagenarians by leptin, IGFBP3 and T3.Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke.Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies.Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery diseasePromoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjectsInnate immunity and aging.Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?YKL-40: a potential biomarker for osteoarthritis.The relation of circulating YKL-40 to levels and decline of lung function in adult life.Plasma YKL-40: a potential new cancer biomarker?YKL-40--an emerging biomarker in cardiovascular disease and diabetes.Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.Macrophage chitinase 1 stratifies chronic obstructive lung disease.Novel inflammatory marker in dialysis patients: YKL-40.Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.Plasma YKL-40 Elevation on Admission and Follow-Up Is Associated with Diastolic Dysfunction and Mortality in Patients with Acute Myocardial Infarction.The ageing immune system and its clinical implications
P2860
Q24656942-53C78FAC-9EBA-4BA2-810A-D30F16F3E3B3Q28570411-EDAF5255-9E00-4B40-A9F0-8F4E00548A9FQ33701312-D16C153C-F802-4E01-B61F-9D5CE132FAE7Q33745338-07A9D351-79DA-4EAE-A928-48CAF90030E5Q34399182-EDB3DA98-CACF-4AF0-A14A-43B3B9A2F41AQ34494109-192E9007-C3FA-4A48-9EBC-B7CEC2F491A3Q34834538-672EF451-CDD9-49B0-BA61-10AE67E0AFB5Q35557987-F609F0B9-6DD0-4F77-8C1C-1DBBE70FA6CFQ36929586-8DE8E728-2F5B-406F-A052-A6EC2B511A32Q37273123-7631D831-7312-4E82-A5DB-2AB82AB9D6E3Q37334247-05CFA45B-7FD6-4979-9C85-42CEA447EDCDQ37392423-A566360D-0146-4000-8EF0-40B4E16D25D3Q37395897-C9F69F65-E432-40B3-B2F4-2FC39F7F542EQ37605869-575FB625-7CD3-4266-B942-501FEEF55E20Q37636543-9B574309-1B61-4FEC-9BCA-807DA04A5884Q37807414-CB070185-8F30-49FB-BFEA-CF8CB6DA256DQ42559997-0B95760B-D6F6-4C95-951C-9D8D7F6E1A3EQ46103273-F345BCEE-77D8-49B3-862B-F1852B062B0BQ47325932-9CA59EA6-64C9-49EA-BD9C-4E0ED009C001Q55080561-6E0F8138-333D-4072-B5B3-4BE3F93E5BEAQ58045474-F5D6BEDE-964E-4CB6-BB3C-6FC59031E4D8
P2860
High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
High serum YKL-40 level in a c ...... d risk of all-cause mortality.
@en
High serum YKL-40 level in a c ...... d risk of all-cause mortality.
@nl
type
label
High serum YKL-40 level in a c ...... d risk of all-cause mortality.
@en
High serum YKL-40 level in a c ...... d risk of all-cause mortality.
@nl
prefLabel
High serum YKL-40 level in a c ...... d risk of all-cause mortality.
@en
High serum YKL-40 level in a c ...... d risk of all-cause mortality.
@nl
P2093
P2860
P1476
High serum YKL-40 level in a c ...... d risk of all-cause mortality.
@en
P2093
A N Pedersen
H Bruunsgaard
J S Johansen
P2860
P304
P356
10.1111/J.1365-2249.2007.03561.X
P577
2007-12-06T00:00:00Z